BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12792703)

  • 1. Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis.
    Deguti MM; Sipahi AM; Gayotto LC; Palácios SA; Bittencourt PL; Goldberg AC; Laudanna AA; Carrilho FJ; Cançado EL
    Braz J Med Biol Res; 2003 Jun; 36(6):739-45. PubMed ID: 12792703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations.
    Duseja A; Das R; Nanda M; Das A; Garewal G; Chawla Y
    World J Gastroenterol; 2005 Jan; 11(3):393-5. PubMed ID: 15637751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
    Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G
    Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease].
    Lee D; Jeong SH; Lee M; Cho YA; Kim JW; Park Y; Hwang JH; Kim NY; Lee DH
    Korean J Hepatol; 2007 Jun; 13(2):174-84. PubMed ID: 17585191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.
    Bonkovsky HL; Jawaid Q; Tortorelli K; LeClair P; Cobb J; Lambrecht RW; Banner BF
    J Hepatol; 1999 Sep; 31(3):421-9. PubMed ID: 10488699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
    Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
    Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of the hemochromatosis gene mutation in patients with nonalcoholic steatohepatitis and correlation with degree of liver fibrosis.
    Zamin I; Mattos AA; Mattos AZ; Migon E; Bica C; Alexandre CO
    Arq Gastroenterol; 2006; 43(3):224-8. PubMed ID: 17160239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.
    Valenti L; Dongiovanni P; Fracanzani AL; Santorelli G; Fatta E; Bertelli C; Taioli E; Fiorelli G; Fargion S
    Dig Liver Dis; 2003 Mar; 35(3):172-8. PubMed ID: 12779071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India.
    Dhillon BK; Das R; Garewal G; Chawla Y; Dhiman RK; Das A; Duseja A; Chandak GR
    World J Gastroenterol; 2007 Jun; 13(21):2956-9. PubMed ID: 17589946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia].
    Nie L; Ai XF; Zheng YZ; Li QH; Yang L; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):223-8. PubMed ID: 19731820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron overload and HFE gene mutations in Czech patients with chronic liver diseases.
    Dostalikova-Cimburova M; Kratka K; Stransky J; Putova I; Cieslarova B; Horak J
    Dis Markers; 2012; 32(1):65-72. PubMed ID: 22297603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance-associated hepatic iron overload.
    Mendler MH; Turlin B; Moirand R; Jouanolle AM; Sapey T; Guyader D; Le Gall JY; Brissot P; David V; Deugnier Y
    Gastroenterology; 1999 Nov; 117(5):1155-63. PubMed ID: 10535879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.
    Nelson JE; Brunt EM; Kowdley KV;
    Hepatology; 2012 Nov; 56(5):1730-40. PubMed ID: 22611049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis.
    Nelson JE; Bhattacharya R; Lindor KD; Chalasani N; Raaka S; Heathcote EJ; Miskovsky E; Shaffer E; Rulyak SJ; Kowdley KV
    Hepatology; 2007 Sep; 46(3):723-9. PubMed ID: 17680648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
    Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron overload in kidney transplants: prospective analysis of biochemical and genetic markers.
    Lorenz M; Kletzmayr J; Huber A; Hörl WH; Sunder-Plassmann G; Födinger M
    Kidney Int; 2005 Feb; 67(2):691-7. PubMed ID: 15673318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
    Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Involvement and role of iron in nonalcoholic steatohepatitis].
    Cojocariu C; Trifan A; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):308-12. PubMed ID: 19294996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.